Schlumberger NV
PAR:SLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Schlumberger NV
PAR:SLB
|
US |
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
AU |
|
Chrysalis Investments Ltd
LSE:CHRY
|
GG |
|
Chocoladefabriken Lindt & Spruengli AG
OTC:COCXF
|
CH |
|
Emmi AG
SIX:EMMN
|
CH |
|
BOK Financial Corp
NASDAQ:BOKF
|
US |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
US |
|
L
|
Laurent Perrier SA
F:LPE
|
FR |
|
Y
|
Yara International ASA
XMUN:IU2
|
NO |
|
Five Star Bancorp
NASDAQ:FSBC
|
US |
|
Ningbo Tuopu Group Co Ltd
SSE:601689
|
CN |
|
G
|
Grenergy Renovables SA
XMUN:5GR
|
ES |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
Wall St Price Targets
SLB Price Targets Summary
Schlumberger NV
According to Wall Street analysts, the average 1-year price target for SLB is 46.6 EUR with a low forecast of 32.32 EUR and a high forecast of 55.49 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SLB's stock price target?
Price Target
46.6
EUR
According to Wall Street analysts, the average 1-year price target for SLB is 46.6 EUR with a low forecast of 32.32 EUR and a high forecast of 55.49 EUR.
What is the Revenue forecast for Schlumberger NV?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 5 years is 4%.
What is the Operating Income forecast for Schlumberger NV?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 5 years is 7%.
What is the Net Income forecast for Schlumberger NV?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 5 years is 13%.
